FibroBiologics implements 1-for-20 reverse stock split effective March 30, 2026

FibroBiologics, Inc.

Reverse split ratio of 1:20; every 20 shares converted to 1 share.
No fractional shares issued; any fractional interests rounded up to the nearest whole share.
Par value unchanged at $0.00001; authorized shares unchanged.
CUSIP changed to 31573L204; trading symbol remains 'FBLG'.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

FibroBiologics, Inc.: Implemented a one-for-twenty reverse stock split of common stock via amendment to the Amended and Restated Certificate of Incorporation (effective 2026-03-30).

Change: charter amendment
Effective: 2026-03-30

Exact text from the filing

On March 25, 2026, FibroBiologics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which became effective at 12:01 a.m. Eastern Time on March 30, 2026, and implemented a one-for-twenty (1:20) reverse stock split

View on SEC.gov

102 governance changes filed in the last 30 days. Browse all governance changes →

FibroBiologics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-142089

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.